Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230462 | 1.00 | CYP3A4 (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL1229335 | 1.00 | CYP3A4 (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL2156822 | 0.95 | TSHR (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL1132735 | 0.95 | TSHR (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL1230379 | 0.95 | CYP3A4 (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL10982849 | 0.95 | CYP3A4 (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL407252 | 0.95 | TSHR (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL342872 | 0.95 | CYP3A4 (0.34) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL209175 | 0.93 | CYP3A4 (0.39) | CYP3A4TSHRNFKB1NPSR1CA1 | |
| SCHEMBL1229436 | 0.91 | CYP3A4 (0.37) | CYP3A4TSHRNFKB1NPSR1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1746134-B1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-1746135-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-7973108-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7910681-B2 | Curable composition having improved adhesion | KANEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7893170-B2 | Curable composition having improved curability and adhesion | KANEKA CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20080319152-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080194773-A1 | Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives | KANEKA CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080076878-A1 | Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives | KANEKA CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| EP-1746134-A1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746133-A1 | CURABLE COMPOSITION IMPROVED IN ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746135-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |